ANNOUNCEMENT

Click here to download pdf brochure for MedCity CONVERGE, to be held July 9-10 in Philadelphia.

Topic: AtriCure

AtriCure sees big potential in ‘hybrid’ atrial fibrillation procedure

AtriCure sees big potential in ‘hybrid’ atrial fibrillation procedure

June 24, 2011 11:26 am by | 0 Comments

Cardiac medical device maker AtriCure (NASDAQ:ATRC) sees big opportunity in a new “hybrid” procedure that treats atrial fibrillation with a combination of ablation from inside and outside of the heart.But ... Read more
AtriCure: Atrial fibrillation trial to be ‘inflection point’ for business

AtriCure: Atrial fibrillation trial to be ‘inflection point’ for business

May 4, 2011 11:58 am by | 0 Comments

The launch of a pivotal clinical trial next year for a “hybrid” procedure to treat atrial fibrillation patients will be an “inflection point” for cardiac surgical device maker AtriCure’s (NASDAQ:ATRC) ... Read more
AtriCure founder’s next medical device venture: Enable Injections

AtriCure founder’s next medical device venture: Enable Injections

April 5, 2011 2:08 pm by | 0 Comments

AtriCure (NASDAQ:ATRC) founder Michael Hooven‘s next project could change the way children are injected with vaccines.But you won’t hear that from him.Hooven politely declined to provide much detail on Cincinnati-based ... Read more
AtriCure reports first-ever profitable quarter

AtriCure reports first-ever profitable quarter

February 16, 2011 1:58 pm by | 0 Comments

Cardiac surgical device maker AtriCure Inc. (NASDAQ:ATRC) has reported its first-ever profitable quarter as sales of its AtriClip device continue to climb. AtriCure's better-than-expected financial results sent its shares up ... Read more
AtriCure upgraded to ‘Buy’ by Roth Capital, target price raised 30%

AtriCure upgraded to ‘Buy’ by Roth Capital, target price raised 30%

January 4, 2011 11:25 am by | 0 Comments

Investment bank Roth Capital Partners has upgraded shares of AtriCure Inc. (NASDAQ:ATRC) to "Buy" and raised its target price by nearly 30 percent. ... Read more
Atricure enrolls first patient in atrial fibrillation trial

Atricure enrolls first patient in atrial fibrillation trial

December 2, 2010 12:11 pm by | 0 Comments

Cardiac medical device maker AtriCure Inc. (NASDAQ:ATRC) has enrolled the first patient in a clinical trial designed to test a hybrid procedure on patients with persistent atrial fibrillation, a condition ... Read more
AtriCure’s Q3 revenues rise 9 percent on AtriClip sales

AtriCure’s Q3 revenues rise 9 percent on AtriClip sales

November 2, 2010 9:21 am by | 0 Comments

Revenues continue to rise for medical device maker AtriCure Inc. (NASDAQ:ATRC), though the company still posted a net loss in the third quarter. ... Read more
AtriCure could pay $2.8M to settle claims it mis-marketed devices

AtriCure could pay $2.8M to settle claims it mis-marketed devices

August 24, 2010 11:59 am by | 0 Comments

AtriCure Inc. (Nasdaq: ATRC) has agreed to pay $2.8 million to settle a class-action shareholder lawsuit that stems from claims that it promoted its surgical cardiac ablation devices for ... Read more
AtriCure rides a-fib momentum to smallest quarterly loss

AtriCure rides a-fib momentum to smallest quarterly loss

August 4, 2010 1:42 pm by | 0 Comments

Riding high on an approval to sell a major new product in the United States, AtriCure Inc. (NASDAQ: ATRC) posted its smallest net loss ever during the second quarter — ... Read more
AtriCure: A superhero wearing an underdog’s uniform?

AtriCure: A superhero wearing an underdog’s uniform?

June 15, 2010 11:50 pm by | 1 Comments

Shares of West Chester, Ohio-based AtriCure Inc. (NASDAQ: ATRC) rose more than 20 percent Tuesday, a day after the Food and Drug Administration approved the company’s AtriClip system for sale ... Read more
AtriCure gets FDA clearance to begin selling AtriClip device

AtriCure gets FDA clearance to begin selling AtriClip device

June 14, 2010 5:19 pm by | 0 Comments

AtriCure Inc. (NASDAQ: ATRC) has received regulatory clearance to begin U.S. sales of its AtriClip device, which protects against blood clots during certain heart procedures.The news sent AtriCure’s stock soaring ... Read more
AtriCure gets FDA nod to try hybrid atrial fibrillation procedure

AtriCure gets FDA nod to try hybrid atrial fibrillation procedure

May 10, 2010 4:36 pm by | 0 Comments

Updated 8:10 p.m., May 10, 2010.Atricure Inc. (NASDAQ: ATRC), the maker of cardiac surgical ablation systems, has received a conditional nod from the Food and Drug Administration (FDA) to evaluate ... Read more
Ohio companies have ‘nowhere to go’ to avoid device sales tax

Ohio companies have ‘nowhere to go’ to avoid device sales tax

April 7, 2010 3:30 pm by | 0 Comments

Ohio’s medical device makers are still trying to figure out what the new 2.3 percent sales tax on their products–compliments of health care reform–will mean for them.The tax on sales ... Read more
Night Read (Ohio): US Endoscopy releases colonoscopy product

Night Read (Ohio): US Endoscopy releases colonoscopy product

March 3, 2010 9:42 pm by | 0 Comments

US Endoscopy, the endoscopy device design and manufacturing company in Mentor, has released the Entrada colonic overtube, which offers more control during colonoscopy in patients with tortuous sigmoid looping. ... Read more
Despite challenges, AtriCure advanced toward profitability, added regulator approvals in 2009

Despite challenges, AtriCure advanced toward profitability, added regulator approvals in 2009

February 18, 2010 2:43 pm by | 0 Comments

Despite several challenges in 2009--like a Department of Justice investigation and related whistle-blower lawsuit--AtriCure Inc. advanced toward profitability, added regulator approvals for its cardiac surgical ablation systems and developed new ... Read more